The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious Uveitis

NCT00646425 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-infectious Uveitis

Interventions

DRUG: Basiliximab
DRUG: Placebo

Sponsor

Cerimon Pharmaceuticals

Collaborators

[object Object]